APA (7th ed.) Citation

R, B., A, R., S, M., A, A., F, A., D, A., . . . G, K. (2025). Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma. Blood advances, 9(9), 2336. https://doi.org/10.1182/bloodadvances.2025016131

Chicago Style (17th ed.) Citation

R, Banerjee, et al. "Universal Driving Restrictions Beyond 4 weeks Appear Unnecessary Following CAR-T Therapy in Multiple Myeloma." Blood Advances 9, no. 9 (2025): 2336. https://doi.org/10.1182/bloodadvances.2025016131.

MLA (9th ed.) Citation

R, Banerjee, et al. "Universal Driving Restrictions Beyond 4 weeks Appear Unnecessary Following CAR-T Therapy in Multiple Myeloma." Blood Advances, vol. 9, no. 9, 2025, p. 2336, https://doi.org/10.1182/bloodadvances.2025016131.